These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22321253)

  • 1. The effect of CCND1 +870A>G and VEGF +936C>T polymorphisms on oral cancer development and disease-free survival in a Taiwan population.
    Lin YC; Yeh CJ; Wang LH; Lee CW; Chen CH
    Oral Oncol; 2012 Jun; 48(6):535-40. PubMed ID: 22321253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients.
    Supic G; Jovic N; Zeljic K; Kozomara R; Magic Z
    Oral Oncol; 2012 Nov; 48(11):1171-7. PubMed ID: 22818823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer.
    Heist RS; Zhai R; Liu G; Zhou W; Lin X; Su L; Asomaning K; Lynch TJ; Wain JC; Christiani DC
    J Clin Oncol; 2008 Feb; 26(6):856-62. PubMed ID: 18281657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.
    Absenger G; Szkandera J; Stotz M; Pichler M; Winder T; Langsenlehner T; Langsenlehner U; Samonigg H; Renner W; Gerger A
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E96-102. PubMed ID: 23625573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
    Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
    Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.
    Matthias C; Branigan K; Jahnke V; Leder K; Haas J; Heighway J; Jones PW; Strange RC; Fryer AA; Hoban PR
    Clin Cancer Res; 1998 Oct; 4(10):2411-8. PubMed ID: 9796972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between single-nucleotide polymorphisms of the VEGF gene and long-term prognosis of oral squamous cell carcinoma.
    Kämmerer PW; Koch FP; Schiegnitz E; Kumar VV; Berres M; Toyoshima T; Al-Nawas B; Brieger J
    J Oral Pathol Med; 2013 May; 42(5):374-81. PubMed ID: 23227881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
    Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of evidence for predictive and prognostic value of cyclin D1 gene polymorphism CCND1 G870A for oral squamous cell carcinoma.
    Atac A; Riecke B; Assaf AT; Gröbe A; Friedrich RE; Heiland M; Izbicki JR; Kluwe L; Blessmann M
    Anticancer Res; 2014 Jan; 34(1):235-8. PubMed ID: 24403468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer.
    Bae SJ; Ahn DH; Hong SP; Kang H; Hwang SG; Oh D; Kim NK
    Yonsei Med J; 2008 Oct; 49(5):783-91. PubMed ID: 18972599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization for detecting genomic alterations of cyclin D1 and p16 in oral squamous cell carcinomas.
    Uzawa N; Sonoda I; Myo K; Takahashi K; Miyamoto R; Amagasa T
    Cancer; 2007 Nov; 110(10):2230-9. PubMed ID: 17893905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of cyclin D1 polymorphism with increased susceptibility to oral squamous cell carcinoma.
    Holley SL; Matthias C; Jahnke V; Fryer AA; Strange RC; Hoban PR
    Oral Oncol; 2005 Feb; 41(2):156-60. PubMed ID: 15695117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF polymorphisms in early cervical cancer susceptibility, angiogenesis, and survival.
    Kim YH; Kim MA; Park IA; Park WY; Kim JW; Kim SC; Park NH; Song YS; Kang SB
    Gynecol Oncol; 2010 Nov; 119(2):232-6. PubMed ID: 20797778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cyclin D1 genotype with breast cancer risk and survival.
    Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of genetic polymorphisms in the VEGF gene with breast cancer survival.
    Lu H; Shu XO; Cui Y; Kataoka N; Wen W; Cai Q; Ruan ZX; Gao YT; Zheng W
    Cancer Res; 2005 Jun; 65(12):5015-9. PubMed ID: 15958542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab.
    Zhang W; Gordon M; Press OA; Rhodes K; Vallböhmer D; Yang DY; Park D; Fazzone W; Schultheis A; Sherrod AE; Iqbal S; Groshen S; Lenz HJ
    Pharmacogenet Genomics; 2006 Jul; 16(7):475-83. PubMed ID: 16788380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-existence of cyclin D1 and vascular endothelial growth factor protein expression is a poor prognostic factor for UICC stage I-III colorectal cancer patients after curative resection.
    Tsai HL; Yeh YS; Chang YT; Yang IP; Lin CH; Kuo CH; Juo SH; Wang JY
    J Surg Oncol; 2013 Feb; 107(2):148-54. PubMed ID: 22926658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM Stage I and II squamous cell carcinoma of the oral cavity.
    Myo K; Uzawa N; Miyamoto R; Sonoda I; Yuki Y; Amagasa T
    Cancer; 2005 Dec; 104(12):2709-16. PubMed ID: 16265665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients.
    Gal TJ; Huang WY; Chen C; Hayes RB; Schwartz SM
    Laryngoscope; 2005 Dec; 115(12):2221-31. PubMed ID: 16369171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies.
    Miyamoto R; Uzawa N; Nagaoka S; Nakakuki K; Hirata Y; Amagasa T
    Cancer; 2002 Nov; 95(10):2152-9. PubMed ID: 12412169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.